Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market ...

Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected.

Reports Q3 adjusted EBITDA $5.694M vs. $3.465M. “In Q3, we delivered our second consecutive quarter of record revenue driven by the acquisition of ...

OrganiGram (OGI) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.02 per share a year ago. These figures are ...

TORONTO (AP) — TORONTO (AP) — Organigram Global Inc. (OGI) on Wednesday reported a loss of $4.5 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss ...

Analysts expect OrganiGram Holdings to report an earnings per share (EPS) of $-0.01. The announcement from OrganiGram Holdings is eagerly anticipated, with investors seeking news of surpassing ...

We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Organigram Global Inc. stands sixth ...

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include Organigram Inc. and Laurentian Organic Inc. licensed producers of cannabis ...

OrganiGram’s revenue growth is very impressive. With plenty of cash in hand, in my view, the company’s acquisitions and further product development will likely serve as revenue catalysts.

At the very end of 2023, I explained why Organigram (NASDAQ: OGI) was my favorite cannabis stock. It still is! The stock is up a lot this year, and my ownership in my model portfolio of a 19.5% ...

It was May 21, 2019 when OrganiGram first began trading on the Nasdaq. Since then the stock has lost more than 80% of its value -- by comparison, the Marijuana Life Sciences ETF has fallen by 71%.